ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2009;88:1451-1456. doi:10.1016/j.athoracsur.2009.07.006
© 2009 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marco Ranucci
Marisa Di Donato
Lorenzo Menicanti
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Castelvecchio, S.
Right arrow Articles by Menicanti, L.
PubMed
Right arrow Articles by Castelvecchio, S.
Right arrow Articles by Menicanti, L.
Related Collections
Right arrow Cardiac - other


Original Articles: Adult Cardiac

Diabetes Mellitus and Long-Term Outcome in Heart Failure Patients After Surgical Ventricular Restoration

Serenella Castelvecchio, MDa,b,*, Marco Ranucci, MDb, Marisa Di Donato, MDc, Lorenzo Menicanti, MDa

a Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan, Italy
b Department of Cardiothoracic and Vascular Anesthesia & ICU, IRCCS Policlinico San Donato, Milan, Italy
c Department of Critical Care Medicine, University of Florence, Florence, Italy

Accepted for publication July 2, 2009.

* Address correspondence to Dr Castelvecchio, Department of Cardiac Surgery, IRCCS, Policlinico San Donato, Via Morandi 30, San Donato Milanese, Milan, 20097, Italy (Email: castelvecchio.serenella{at}gmail.com).

Background: This study aimed to identify the impact of diabetes mellitus and related comorbidities on long-term survival of heart failure patients who had undergone surgical ventricular restoration. Surgical ventricular restoration is an optional therapeutic strategy for patients with ischemic dilated cardiomyopathy. Reported prognostic predictors for late morbidity and mortality are predominantly related to cardiac conditions, whereas the prognostic impact of comorbidities still needs to be defined.

Methods: A total of 329 patients (234 nondiabetic and 95 diabetic) who survived the surgical ventricular restoration operation were admitted to this study. Cardiac mortality follow-up data were collected. Actuarial survival curves were calculated for the two groups; differences between groups and the impact of other comorbidities were established using a log-rank test and a Cox regression analysis.

Results: The mean follow-up time was 44 months. Diabetic patients had a significantly worse survival rate: at 5 years, their survival rate was 81%, versus 89% for nondiabetic patients (p = 0.019). Other comorbidities significantly associated with the survival rate were chronic renal failure, New York Heart Association class, and liver dysfunction. Diabetic patients without comorbidities had a survival rate similar to that of nondiabetic patients. Diabetic patients with at least one comorbidity had a significantly worse outcome. Diabetic patients with chronic renal failure had a 5-year survival rate of 40%, versus 85% for nondiabetic patients (p = 0.002).

Conclusions: Noncomplicated diabetes has no negative impact on long-term survival after surgical ventricular restoration. Conversely, complicated diabetes, namely the presence of chronic renal failure, carries a long-term cardiac mortality risk that is four times higher than the risk for nondiabetic patients.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The Society of Thoracic Surgeons.